logo
People Are Reporting A Frightening COVID Symptom Right Now — Here's What To Know

People Are Reporting A Frightening COVID Symptom Right Now — Here's What To Know

Yahooa day ago

A positive COVID-19 test result is not something that anyone wants to see — but now there may be an extra reason to avoid getting sick.
COVID infections cause miserable symptoms such as fever, fatigue, congestion and more. Now, though, some people infected with COVID in China are reporting a very sore throat that's been nicknamed 'razor blade throat.'
According to Google trends data, people throughout the U.S. are now, too, worried about this scary-sounding symptom and are searching for things like 'new covid variant painful symptom' and 'covid razor throat.'
Just how worried do you need to be about a super-painful sore throat during a COVID infection? Below, doctors weigh in on the supposed 'razor blade' sore throat symptom:
'In the past, as new variants have come on the scene, there almost invariably have been questions about distinctive symptoms, and after a while, when you gather a lot of data, turns out not to be the case — all of these symptoms have occurred before,' said Dr. William Schaffner, a professor of preventive medicine in the department of health policy at Vanderbilt University Medical Center in Nashville, Tennessee.
Meaning, the circulating COVID variants tend to produce the same sort of symptoms and disease as the ones from years ago, Schaffner added. 'Although the more recent variants, these omicron variants, are less severe,' he said.
A very sore throat isn't specific to the circulating COVID variants, said Dr. Carrie Horn, the chief medical officer and chief of the division of hospital and internal medicine at National Jewish Health in Colorado. Instead, it's a symptom that has been associated with COVID infections for a while, Horn said.
Schaffner had not heard of the 'razor blade' sore throat symptom particularly, but has heard of people having a severe sore throat with COVID infections.
While some people can have a very sore throat that could be described as razor-like, it doesn't mean it's going to happen to everyone — and it also isn't some new, scary symptom that is associated with new COVID infections.
There is not one outstanding COVID symptom that marks an infection, said Dr. Mark Burns, an infectious disease expert at UofL Health in Louisville, Kentucky. 'A sore throat is a symptom of this, but also fever and cough and fatigue, these are all symptoms as well,' Burns added.
'To sum it all up, the symptoms, including sore throat, are really no different. There's no increased intensity based on sore throat or anything like that,' added Burns.
COVID tends to surge twice a year — once in the winter and once in the mid-to-late summer, Schaffner said.
'And so there has been a longstanding recommendation by the CDC's Advisory Committee on Immunization Practices that people who are at increased risk of getting severe COVID should actually get two COVID vaccinations a year. Obviously, one in the fall to prevent the winter increase, but another right now in order to help prevent serious disease during the late summer and early fall,' Schaffner said.
This goes for people 65 and older, younger people with underlying chronic medical conditions and pregnant people, he said.
'The recommendation is take special precautions and get that extra dose, because if we get infected ... we get that extra protection and to help keep us out of the hospital,' Schaffner said.
Wearing a mask in indoor spaces, social distancing, washing your hands often and increasing ventilation when possible are more ways to protect yourself from COVID and other respiratory viruses, too, said Burns.
If you have any COVID symptoms, such as sore throat, fatigue, cough or fever, take a test to see if you have COVID. If you are infected, get in touch with your doctor, particularly if you're high-risk as there are treatments available, said Schaffner.
It's important that you talk to your primary care provider as the guidance will vary depending on your age, underlying conditions and other risk factors.
COVID is a miserable infection, Horn added. 'Over-the-counter meds help — Ibuprofen alternating with Tylenol, if you're able to take those ... there's no reason to be miserable,' Horn said. 'So, take the medicine that you are able to take to help,' she said.
It's also important to stay hydrated when you're sick even if you do have a painful sore throat. A sore throat can make hydration feel like more of a chore, but it's important to drink water and herbal teas as dehydration can further irritate the dry membranes in your throat, Horn said.
'If you are sick, it's best to keep your germs to yourself,' said Horn. This means canceling the dinner plans, not going to the party and calling out of work if you can — if you can't, wearing a tight-fitting mask is key, Horn added.
'Preventing transmission is the biggest thing that we can do to help keep everybody healthy,' Horn said.
A New COVID Variant Is Here, And It's More Transmissible — Here Are The Signs And Symptoms
RFK Jr. Wants To Take COVID Shots Away From Pregnant People — But You Can Fight Back
CDC Changes COVID Vaccine Recommendations — But Doesn't Go As Far As RFK Jr. Wanted

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Biden's COVID czar hammers RFK Jr. over vaccine panel overhaul
Biden's COVID czar hammers RFK Jr. over vaccine panel overhaul

Yahoo

time2 hours ago

  • Yahoo

Biden's COVID czar hammers RFK Jr. over vaccine panel overhaul

Former White House COVID-19 response coordinator Ashish Jha, who served under former President Biden, criticized the decision by Health and Human Services Secretary Robert F. Kennedy Jr. to fire all 17 experts on the U.S. Centers for Disease Control and Prevention's (CDC) vaccine panel. Kennedy announced the decision in an op-ed for The Wall Street Journal on Monday, saying, 'A clean sweep is needed to re-establish public confidence in vaccine science.' But in an interview with CNN's Wolf Blitzer, Jha pushed back against Kennedy's reasoning. 'Look, what he said in his op-ed was a series of nonsense about a group of individuals, experts …who shape what vaccines, if any, are going to be available to the American people,' Jha said in the interview. 'So obviously this is very concerning,' he continued. 'We'll have to see who he appoints next. But this is a step in the wrong direction.' Jha said he is concerned about what the move foretells about the secretary's agenda on vaccines. Jha pointed to what he characterized as a lackluster response from the secretary to 'the worst measles outbreak of the last 25 years.' He also expressed concern regarding Kennedy's raising questions about vaccines causing autism, which Jha dismissed and said was 'settled science.' 'Then you put this in the middle of all of that,' Jha said, referring to the vaccine panel sweep, 'and what you have is a pretty clear picture that what Secretary Kennedy is trying to do is make sure that vaccines are not readily available to Americans, not just for kids, for the elderly.' 'He could go pretty far with this move, and I really am worried about where we're headed,' Jha continued. He said he's particularly concerned about the effect Kennedy's move will have on kids and whether they will continue having access to certain vaccines in the future. 'Kids rely on vaccines. I'm worried about whether the next generation of kids are going to have access to polio vaccines and measles vaccines. That's where we're heading. That's what we have to push back against.' Kennedy said in his op-ed that he was removing every member of the panel to give the Trump administration an opportunity to appoint its own members. Kennedy has long accused members of the Advisory Committee on Immunization Practices of having conflicts of interest, sparking concern among vaccine advocates that he would seek to install members who are far more skeptical of approving new vaccines. But Jha pushed back against criticism that the panel was all Biden-appointed experts, saying, 'When the Biden administration came in, almost all of the appointees had come from the first Trump administration.' 'That was fine because they were good people,' he said. 'They were experts. Right now, it's the same thing. The people he is firing are experts — like a nurse in Illinois who spent her entire career getting kids vaccinated, cancer doctors from Memorial Sloan Kettering — like these are really good people.' 'And generally, CDC has not worried about when were they appointed. The question is, are they good and are they conflict free.' Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

UAMS chancellor stepping down after 7 years, returning to faculty
UAMS chancellor stepping down after 7 years, returning to faculty

Yahoo

time4 hours ago

  • Yahoo

UAMS chancellor stepping down after 7 years, returning to faculty

UAMS Chancellor Cam Patterson announces a new $31.7 million grant from the National Institutes of Health on July 10, 2024. (Mary Hennigan/Arkansas Advocate) The leader of Arkansas' largest healthcare system will step down after seven years for personal and medical reasons, the University of Arkansas for Medical Sciences announced Tuesday in a news release. Dr. Cam Patterson became the university's chancellor in June 2018. By giving up his position as chancellor and as UAMS Health CEO, he will return to being a faculty member in the university's cardiology department. Patterson 'is facing medical and personal issues that require more attention than he can give them while serving in the chancellor's position,' according to UAMS' news release. 'The work our team has done at UAMS over the last seven-plus years has been the high point of my career,' Patterson said in the release. 'We have a lot to be proud of and I've been the luckiest guy to be a part of it. I am excited about the opportunity to return to the faculty and engage more deeply in the academic and clinical missions at our institution.' UAMS System President Jay Silveria praised Patterson's leadership tenure in the release. 'Leading UAMS is a demanding task, and I appreciate Dr. Patterson's need to do what he feels is best for himself and his family and for the long-term success of the university,' Silveria said. 'His contributions to UAMS came through unusually restrictive times, and he should be celebrated for his efforts to push the institution forward while navigating a challenging environment.' Patterson 'oversaw both challenges and improvement in the university's economic outlook, despite the myriad issues presented by the COVID-19 pandemic and other unforeseen variables,' the release states. One such challenge was a conflict between state and federal mandates regarding COVID-19 vaccinations. The federal Centers for Medicare and Medicaid Services issued a mandate in November 2021 for health workers to be fully vaccinated or receive exemptions, with noncompliant facilities at risk of losing federal funding. The rule directly conflicted with a 2021 Arkansas law that said COVID-19 vaccination 'shall not be a condition of education, employment, entry, or services from the state or a state agency or entity' unless lawmakers approved an exception. Patterson sought an exemption and defended this decision before a legislative committee. Silveria will name an interim UAMS chancellor 'in the coming weeks' and start a national search for Patterson's permanent successor, the news release states. SUPPORT: YOU MAKE OUR WORK POSSIBLE

Rare cancer diagnoses surge dramatically among millennials and Gen X
Rare cancer diagnoses surge dramatically among millennials and Gen X

Yahoo

time4 hours ago

  • Yahoo

Rare cancer diagnoses surge dramatically among millennials and Gen X

A rare type of cancer is growing among millennials and members of Generation X, new research shows. Diagnoses of appendix cancer have tripled in the U.S. for people born between 1976 and 1984 — and it has quadrupled for those born between 1981 and 1989. The study was published on Monday in the Annals of Internal Medicine. Common Menopause Medication Might Prevent Breast Cancer While Treating Hot Flashes Researchers from the Vanderbilt University Medical Center analyzed data from the National Cancer Institute's Surveillance, Epidemiology and End Results (SEER) Program to arrive at these findings. "When you take these alarming rates that we are seeing for appendiceal cancer across generations, together with the fact that one in every three patients diagnosed with appendiceal cancer is diagnosed under the age of 50, these point to a timely need for everyone to be aware of the signs and symptoms of appendix cancer," said lead author Andreana Holowatyj, PhD, assistant professor of Medicine at Vanderbilt University Medical Center and Vanderbilt-Ingram Cancer Center, in a press release from the university. Read On The Fox News App Fda Approves First Ai Tool To Predict Breast Cancer Risk Cancer of the appendix is rare, affecting only about one or two people per million each year in the U.S., according to the National Cancer Institute (NCI). Even so, doctors emphasize the importance of seeking medical attention if symptoms emerge. "Ruling out the possibility of an appendix cancer diagnosis, or diagnosing it early, is important for this cancer as we continue to learn what factors may be contributing to this worrisome trend," Holowatyj said. Appendiceal cancer forms in the appendix, which is a small organ located in the lower right abdomen. There are two main types: epithelial appendiceal cancer, which involves the cells of the lining of the appendix, and neuroendocrine appendiceal cancer, which results from the growth of neuroendocrine (carcinoid) tumors of the appendix, the NCI states. In early stages of the disease, most people do not notice symptoms. As the cancer progresses, common symptoms include pain, a bloated feeling, a mass in the abdomen, nausea and vomiting, and sudden feelings of fullness while eating, according to the above source. Common treatments for this type of cancer include surgery to remove the appendix and any other affected organs, as well as chemotherapy to kill any metastasized cancer cells. Based on the study findings, the researchers are calling for increased awareness among both the public and the medical community. Click Here To Sign Up For Our Health Newsletter "As incidence rates in younger generations are often indicative of future disease burden, these results support the need for histology-specific investigations of appendiceal adenocarcinoma, as well as increased education and awareness of appendiceal adenocarcinomas among healthcare providers and the public," the study stated. There are no standard screening guidelines or risk factors for appendix cancer, which means up to half of diagnoses occur after the disease has already spread, according to the researchers. Five-year survival rates for appendix cancer range from 10% to 63%. For more Health articles, visit The new study received funding from the Appendix Cancer Pseudomyxoma Peritonei (ACPMP) Research Foundation and the National Institutes of article source: Rare cancer diagnoses surge dramatically among millennials and Gen X

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store